Jump Financial, LLC Bio Xcel Therapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$11.19 - $17.89 $52,850 - $84,494	4,723 Added 22.2%	26,000 $307,000
Q2 2022 Aug 09, 2022	BUY	$9.03 - $21.55 $192,131 - $458,519	21,277 New	21,277 $281,000
Q4 2021 Feb 10, 2022	SELL	$20.12 - $35.09 $160,296 - $279,562	-7,967 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$23.84 - $32.03 $10,155 - $13,644	-426 Reduced 5.08%	7,967 $242,000
Q2 2021 Aug 13, 2021	SELL	$29.06 - $38.83 $84,477 - $112,878	-2,907 Reduced 25.73%	8,393 $244,000
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $441,152 - $729,979	11,300 New	11,300 $488,000
Q4 2020 Feb 12, 2021	SELL	$42.46 - $56.58 $438,357 - $584,131	-10,324 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$37.44 - $64.63 $386,530 - $667,240	10,324 New	10,324 $448,000

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.41M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.